Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

Andrew S. Levey, Kerry Willis, Vlado Perkovic et al.|American Journal of Kidney Diseases|2019

Cited by 561